Intracavernous vasoactive pharmacotherapy: The impact of a new self- injection device

F. Montorsi, G. Guazzoni, F. Bergamaschi, A. Orlandini, L. Da Pozzo, L. Barbieri, P. Rigatti, D. K. Montague

Research output: Contribution to journalArticle

Abstract

The clinical effects of a new self-injection pen were investigated in 160 impotent patients undergoing intracavernous vasoactive pharmacotherapy. Of the patients previously using insulin syringes for self-injection 90% switched to the pen, since it was considered easier to use and several injections could be performed with the same drug cartridge, thus avoiding the preparation necessary before every single injection with the syringe. Dropout rates were 36% and 12% for patients using the syringe and the pen, respectively (p

Original languageEnglish
Pages (from-to)1829-1833
Number of pages5
JournalJournal of Urology
Volume150
Issue number6
Publication statusPublished - 1993

Keywords

  • drug therapy
  • equipment and supplies
  • impotence

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Intracavernous vasoactive pharmacotherapy: The impact of a new self- injection device'. Together they form a unique fingerprint.

  • Cite this

    Montorsi, F., Guazzoni, G., Bergamaschi, F., Orlandini, A., Da Pozzo, L., Barbieri, L., Rigatti, P., & Montague, D. K. (1993). Intracavernous vasoactive pharmacotherapy: The impact of a new self- injection device. Journal of Urology, 150(6), 1829-1833.